Avoiding future controversies in the Alzheimer's disease space through understanding the aducanumab data and FDA review. Alzforum, 26 May 2023 Dickson SP, Hennessey S, Nicodemus Johnson J, Knowlton N, Hendrix SB. Alzheimers Res Ther.